Literature DB >> 12648227

Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis.

Kati Asumalahti1, Mahreen Ameen, Sari Suomela, Eva Hagforsen, Gerd Michaëlsson, Julie Evans, Margo Munro, Colin Veal, Michael Allen, Joyce Leman, A David Burden, Brian Kirby, Maureen Connolly, Christopher E M Griffiths, Richard C Trembath, Juha Kere, Ulpu Saarialho-Kere, Jonathan N W N Barker.   

Abstract

The PSORS1 locus in the major histocompatibility complex region is the major genetic determinant for psoriasis vulgaris. Within the PSORS1 region reside at least three potential candidate genes for psoriasis susceptibility. Specific allelic variants of the genes HLA-Cw*6, HCR*WWCC, and CDSN*5 are strongly associated with psoriasis vulgaris and are in strong linkage disequilibrium with each other. We have genotyped the three psoriasis vulgaris susceptibility alleles of the PSORS1 locus in two clinical variants of psoriasis (guttate psoriasis and palmoplantar pustulosis) to study whether PSORS1 is also involved in the pathogenesis of these variants. We also asked whether these two clinical subgroups could help us to distinguish the causative gene within the high-risk PSORS1 haplotype. The association of guttate psoriasis with the three PSORS1 susceptibility alleles was similar and even stronger than seen with psoriasis vulgaris. Palmoplantar pustulosis, however, did not show association with any of the three candidate genes at this locus. Finally, no correlation with the age of onset for disease was observed. Our results show conclusively that psoriasis vulgaris and guttate psoriasis have a similar genetic basis for their association to PSORS1, whereas palmoplantar pustulosis appears to be a distinct disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648227     DOI: 10.1046/j.1523-1747.2003.12094.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  30 in total

1.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients.

Authors:  Rotraut Mössner; Yvonne Frambach; Dagmar Wilsmann-Theis; Sabine Löhr; Arnd Jacobi; Ansgar Weyergraf; Michael Müller; Sandra Philipp; Regina Renner; Heiko Traupe; Harald Burkhardt; Külli Kingo; Sulev Kõks; Steffen Uebe; Michael Sticherling; Heinrich Sticht; Vinzenz Oji; Ulrike Hüffmeier
Journal:  J Invest Dermatol       Date:  2015-05-19       Impact factor: 8.551

Review 3.  [Pustular psoriasis].

Authors:  P Weisenseel; D Wilsmann-Theis; C Kahl; K Reich; R Mössner
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 4.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

5.  HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.

Authors:  Markéta Fojtíková; Jirí Stolfa; Peter Novota; Pavlína Cejková; Ctibor Dostál; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

6.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

7.  Lack of association of HLA-C alleles with late-onset psoriasis in the northern Polish population.

Authors:  Aneta Szczerkowska-Dobosz; Katarzyna Niespodziana; Krzysztof Rebała; Joanna Garstecka; Magdalena Lange; Wioletta Barańska-Rybak
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

8.  Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris.

Authors:  T Yoshizaki; N Bandoh; S Ueda; H Nozawa; T Goto; K Kishibe; M Takahara; Y Harabuchi
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

Review 9.  Current and potential immune therapies and vaccines in the management of psoriasis.

Authors:  Benjamin H Kaffenberger; Grace L Lee; Kelly Tyler; Derek V Chan; Wael Jarjour; Maria E Ariza; Marshall V Williams; Henry K Wong
Journal:  Hum Vaccin Immunother       Date:  2014-02-03       Impact factor: 3.452

Review 10.  Genetics of psoriasis and psoriatic arthritis: update and future direction.

Authors:  Kristina Callis Duffin; Vinod Chandran; Dafna D Gladman; Gerald G Krueger; James T Elder; Proton Rahman
Journal:  J Rheumatol       Date:  2008-07       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.